Sign In
Buy HIMS
$28.01
+0.500 (+1.82%)
At Close: Jun 04, 2026
Hims & Hers Health: Roller Coaster Gift
11:23am, Monday, 20'th Oct 2025
Hims & Hers Health launched menopause and low testosterone products in the last month, expanding its addressable market and supporting its $6.5 billion 2030 revenue target. Recent product launches, in
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know
10:01am, Monday, 20'th Oct 2025
Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
What Moved Markets This Week
07:17am, Saturday, 18'th Oct 2025
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
OMCL or HIMS: Which Is the Better Value Stock Right Now?
12:40pm, Friday, 17'th Oct 2025
Investors with an interest in Medical Info Systems stocks have likely encountered both Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks is more attractive to value in
Is Trump Going to Kill the GLP-1 Cash Cow?
11:05am, Friday, 17'th Oct 2025
GLP-1 drugs propelled Novo Nordisk (NVO) and Eli Lilly (LLY) to record profits, with sales exceeding $20 billion amid skyrocketing demand. Both companies cut prices recently to expand access, but Pres
Here's Why Hims & Hers Health, Inc. (HIMS) Fell More Than Broader Market
06:46pm, Thursday, 16'th Oct 2025
Hims & Hers Health, Inc. (HIMS) reached $59.15 at the closing of the latest trading day, reflecting a -5.75% change compared to its last close.
Hims & Hers Elevates Technology-Driven Healthcare Accessibility
01:41pm, Thursday, 16'th Oct 2025
HIMS boosts AI-led care with new technology chief, hormone therapies and a global push via its ZAVA acquisition.
Hims & Hers Stock's 150% Surge Is All Fundamentals—No Novo, No Problem
10:41am, Thursday, 16'th Oct 2025
Hims & Hers Health Inc. (NYSE:HIMS) has become one of 2025's most surprising winners, up more than 150% year-to-date and over 200% in the past twelve months. But what's making Wall Street sit up this
Hims & Hers: Ramping Up A New Billion-Dollar Segment (Rating Upgrade)
09:53am, Thursday, 16'th Oct 2025
I am upgrading Hims & Hers Health, Inc. to a Buy with an $80 price target, implying 30% upside. The new 'Hers' specialty in Menopause is expected to help the company drive over $1B in Hers segment rev
How HIMS Stock Rises To $120?
09:10am, Thursday, 16'th Oct 2025
Hims & Hers stock (NYSE: HIMS) increased by 16% yesterday following its announcement about expanding into the treatment of menopause and perimenopause—a strategic shift indicating that the company i
Hims & Hers Stock Jumps 9% After Huge Announcement
05:00am, Thursday, 16'th Oct 2025
Shares of Hims & Hers (HIMS 16.20%) jumped 9% in trading on Wednesday after the company announced an expansion into menopause and perimenopause specialties on the Hers app. This is the kind of product
Why Hims & Hers Stock Blasted 16% Higher on Wednesday
06:57pm, Wednesday, 15'th Oct 2025
Healthcare products specialist Hims & Hers Health (HIMS 16.20%) stock passed the most crucial exam of all on Wednesday, as investors gave it the thumbs-up. The shares ended the day more than 16% highe
Why Hims & Hers Stock Blasted 16% Higher on Wednesday
06:57pm, Wednesday, 15'th Oct 2025
Healthcare products specialist Hims & Hers Health (HIMS 16.20%) stock passed the most crucial exam of all on Wednesday, as investors gave it the thumbs-up. The shares ended the day more than 16% highe
Hims & Hers to Offer Treatments for Menopause, Perimenopause
09:02am, Wednesday, 15'th Oct 2025
The company expects the new specialty to help the Hers unit to surpass $1 billion in annual revenue next year.
Hers Launches Menopause and Perimenopause Specialty, Taking the Next Step Toward $1B of Hers Revenue in 2026
09:00am, Wednesday, 15'th Oct 2025
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the launch of a new specialty in women's health, offering access to aff
